Article
EZH2 targeting to improve the sensitivity of acquired radio-resistance bladder cancer cells
21 Dec 2021
Abstract excerpt
Among the many treatments for Bladder cancer (BCa) patients, radiotherapy is an effective way to preserve the bladder. However, as the frequency of irradiation increases, the tumor cells appear "acquired radio-resistance" (ARR) and loss the sensitivity to radiotherapy. To explore the molecular mechanism of ARR, two BCa cell lines, 5637 and T24, were enrolled here and their ARR counterparts, 5637R and T24R, were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
